Excellent27 Apr 2020 12:42
Dr Vladislav Sandler, Hemogenyx's Chief Executive Officer commented: "Although Hemogenyx has not traditionally been focused on fighting infectious diseases, we have always been focused on saving lives. In light of the current COVID-19 pandemic, we are determined to use our proprietary technology, expertise and resources to save lives and to alleviate suffering. We are hopeful that our humanized mice will be an indispensable tool for rapidly managing future outbreaks of viral infections."